Por: Jideon F Marques

trial was presented at the American Society of Cataract and Refractive Surgery meeting in Washington DC. After its publication in The New England Journal of Medicine1, we reassessed our text, especially with regard to the use of omega-3 fatty acids. We applaud the researchers’ diligence in examining the value of omega-3 fatty acids. While this study certainly enhances our understanding of dry eye disease, it does not obviate the use of all omega-3 fatty acids, which remain an important treatment option for dry eye disease.

We are grateful to our expert and experienced contributing authors for the hard work and generous thoughtfulness put into sharing their knowledge. To reflect a diversity of perspectives, we recruited leaders in the field throughout North America from a variety of practice settings including university-based and private.